attyloid to showcase innovations in biomarker development at AD/PD™ 2024 conference
We are excited to announce that attyloid will be presenting at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. This esteemed event, known for drawing medical and scientific professionals from around the globe, provides an unparalleled platform for sharing breakthroughs and advancements in the fight against neurodegenerative diseases.
attyloid invites you to join us at Booth 52 to explore the development of oligomer biomarkers in CNS diseases.
March 05-09, 2024 in Lisbon, Portugal